The collaboration with Dyania Health uses AI technology that identified suitable patients in minutes compared to hours ...

ATLANTA, GA / ACCESS Newswire / September 2, 2025 / Ahead of its premier life science event advancing Clinical Trial ...

Treace Announces Clinical Study Data Demonstrating Positive Lapiplasty® and Adductoplasty® Outcomes at the 2025 ACFAS Annual Scientific Conference Provided by GlobeNewswire Mar 28, 2025 11:00am ...

Public companies, which accounted for about half of AI-enabled devices on the market, had a higher rate of recalls and a lower rate of clinical evidence, according to a JAMA study.

Sustained Performance of the Volt PFA System Data from the Volt CE Mark Study showed that after 12 months, Abbott's Volt PFA System delivered: Outstanding long-term performance.

In this Q&A from the 2025 Veeva R&D and Quality Summit, Ibrahim Kamstrup-Akkaoui, vice president of data systems innovation at Novo Nordisk, discusses simplifying system use through the company’s ...

A two-drug combination for treating advanced kidney cancer has shown sustained and durable clinical benefit in more than five years of follow-up, according to a study published in Nature Medicine.

Guardant Health's Shield test shows promising results in colorectal cancer screening, enhancing early detection and patient ...

Revalia Bio Inc., announced a 14.5M seed funding round to support their launch of ‘Human Data Trials' - a new category of pre-clinical research that gives drug developers early, predictive insights ...

An early trial with about 200 people tested the effects of LSD on generalized anxiety disorder and found promising results.